Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Debbie Rigby 12/09/2023

Debbie Rigby takes a look at the latest in research news Weight loss with subcutaneous semaglutide versus other glucagon-like peptide 1 receptor agonists in type 2 diabetes Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) reduce elevated blood glucose levels and induce weight loss. Randomised trials support the superior efficacy of semaglutide over other GLP-1 RAs

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

What does the future look like for CWH/Sigma shareholders?

Definitely trading at a premium. Average investor thinks CWH has heaps more growth in it left

Bob Tran

Pharmacy now just ordinary commerce: Barnes

Record bankruptcy ????????????

Mioko Akiko

Retail workers suffering ‘serious mental and physical harm’

We have a policy of any abuse of staff will lead to patients/customers having restrictions of who they deal with…

Sharon Miller

ACCC announces Chemist Warehouse/Sigma merger decision

Please explain why you don't understand the differences between a corporate structure, and a franchise.

Siya Etzebeth

Research Roundup

Previous Prescribers ‘lack clarity’ on 60-day prescribing

Next Petition calls for 60-day U-turn

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Prescribers ‘lack clarity’ on 60-day prescribing

Next Petition calls for 60-day U-turn

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.